Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,167 | 24,912 | 41,337 | 8,588 | -61,319 |
| Depreciation Amortization | 3,882 | 3,314 | 2,529 | 1,313 | 7,740 |
| Accounts receivable | 672 | 713 | 694 | 511 | -181 |
| Accounts payable and accrued liabilities | -2,096 | -2,168 | -1,982 | -2,102 | 1,508 |
| Other Working Capital | -55,989 | -65,257 | -64,799 | -20,329 | -41,487 |
| Other Operating Activity | -12,081 | -1,276 | -11,629 | -6,962 | 9,625 |
| Operating Cash Flow | $-58,445 | $-39,762 | $-33,850 | $-18,981 | $-84,114 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -190 | -93 | -54 | -26 | -1,850 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 8,000 |
| Purchase Sale Intangibles | -25 | -25 | N/A | N/A | -321 |
| Other Investing Activity | -25 | -25 | 0 | 0 | -321 |
| Investing Cash Flow | $-215 | $-118 | $-54 | $-26 | $5,829 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 22,468 | 22,488 | N/A | N/A | N/A |
| Common Stock Issued | 50,487 | 44,547 | 40,797 | 40,095 | 5,387 |
| Other Financing Activity | -22,505 | -22,505 | 0 | 0 | 0 |
| Financing Cash Flow | $50,450 | $44,530 | $40,797 | $40,095 | $5,387 |
| Beginning Cash Position | 116,678 | 116,678 | 116,678 | 116,678 | 189,576 |
| End Cash Position | 108,468 | 121,328 | 123,571 | 137,766 | 116,678 |
| Net Cash Flow | $-8,210 | $4,650 | $6,893 | $21,088 | $-72,898 |
| Free Cash Flow | |||||
| Operating Cash Flow | -58,445 | -39,762 | -33,850 | -18,981 | -84,114 |
| Capital Expenditure | -250 | -153 | -114 | -86 | -1,957 |
| Free Cash Flow | -58,695 | -39,915 | -33,964 | -19,067 | -86,071 |